80 research outputs found

    PENGURANGAN KUNING TELUR PADA BEBERAPA KONSENTRASI GUM XANTHAN TERHADAP KARAKTERISTIK FISIKOKIMIA DAN ORGANOLEPTIK CAKE BERAS RENDAH LEMAK

    Get PDF
    Reducing levels of fat content in reduced fat rice cake can be done by reducing the use of egg yolk. Egg yolk reduction causes the changes of characteristics of reduced fat rice cake so that need the addition of an other compounds that can improve the characteristics of reduced fat rice cake. Gum xanthan can be used to improve the characteristics of reduced fat rice cake is. This research objective to determine the effect of egg yolk reduction and gum xanthan concentration and interaction on physicochemical and sensory properties of reduced fat rice cake. Research design was Randomized Block Design with factorial design that consisted of two factors, namely egg yolk reduction and gum xanthan concentration. Reduced egg yolk consisted of two levels, 60% and 80% from the based formula of egg yolk meanwhile gum xanthan concentration consisted of three levels, 0,1%; 0,2% and 0,3% from the weight of rice flour. The research was conducted in four replications. Data were analyzed using Analysis of Variance at α = 5%. If the ANOVA test showed a significant effect, data were analyzed by Duncan’s Multiple Range Test at α = 5% to determine the level of treatments that gave a significant difference. The results showed the interaction between egg yolk reduction and gum xanthan concentration provided significant effect on moisture content, specific volume, hardness, gumminess and color reduced fat rice cake. Egg yolk reduction provided significant effect on texture characteristics, such as springiness, cohesiveness and chewiness while gum xanthan concentration provided significant effect on texture characteristics, such as chewiness reduced fat rice cake. Egg yolk reduction at gum xanthan concentration variation provided significant effect on preference of color, pore uniformity, softness, taste and swallowability (moistness) reduced fat rice cake. Reduced fat rice cake with 60% egg yolk reduction and 0,1% gum xanthan concentration was the most preferred treatment.Keywords: reduced fat rice cake, egg yolk reduction, gum xantha

    Retrospective evaluation of whole exome and genome mutation calls in 746 cancer samples

    No full text
    Funder: NCI U24CA211006Abstract: The Cancer Genome Atlas (TCGA) and International Cancer Genome Consortium (ICGC) curated consensus somatic mutation calls using whole exome sequencing (WES) and whole genome sequencing (WGS), respectively. Here, as part of the ICGC/TCGA Pan-Cancer Analysis of Whole Genomes (PCAWG) Consortium, which aggregated whole genome sequencing data from 2,658 cancers across 38 tumour types, we compare WES and WGS side-by-side from 746 TCGA samples, finding that ~80% of mutations overlap in covered exonic regions. We estimate that low variant allele fraction (VAF < 15%) and clonal heterogeneity contribute up to 68% of private WGS mutations and 71% of private WES mutations. We observe that ~30% of private WGS mutations trace to mutations identified by a single variant caller in WES consensus efforts. WGS captures both ~50% more variation in exonic regions and un-observed mutations in loci with variable GC-content. Together, our analysis highlights technological divergences between two reproducible somatic variant detection efforts

    Reducing the environmental impact of surgery on a global scale: systematic review and co-prioritization with healthcare workers in 132 countries

    Get PDF
    Abstract Background Healthcare cannot achieve net-zero carbon without addressing operating theatres. The aim of this study was to prioritize feasible interventions to reduce the environmental impact of operating theatres. Methods This study adopted a four-phase Delphi consensus co-prioritization methodology. In phase 1, a systematic review of published interventions and global consultation of perioperative healthcare professionals were used to longlist interventions. In phase 2, iterative thematic analysis consolidated comparable interventions into a shortlist. In phase 3, the shortlist was co-prioritized based on patient and clinician views on acceptability, feasibility, and safety. In phase 4, ranked lists of interventions were presented by their relevance to high-income countries and low–middle-income countries. Results In phase 1, 43 interventions were identified, which had low uptake in practice according to 3042 professionals globally. In phase 2, a shortlist of 15 intervention domains was generated. In phase 3, interventions were deemed acceptable for more than 90 per cent of patients except for reducing general anaesthesia (84 per cent) and re-sterilization of ‘single-use’ consumables (86 per cent). In phase 4, the top three shortlisted interventions for high-income countries were: introducing recycling; reducing use of anaesthetic gases; and appropriate clinical waste processing. In phase 4, the top three shortlisted interventions for low–middle-income countries were: introducing reusable surgical devices; reducing use of consumables; and reducing the use of general anaesthesia. Conclusion This is a step toward environmentally sustainable operating environments with actionable interventions applicable to both high– and low–middle–income countries

    Telomeres and telomerase in head and neck squamous cell carcinoma: from pathogenesis to clinical implications

    Full text link

    Pembuatan Sistem Knowledge Management Berbasis Web pada PT Benua Cakra Petrolindo

    No full text
    Knowledge Management merupakan sebuah proses merencanakan, mengumpulkan dan mengorganisir, memimpin dan mengendalikan data dan informasi yang telah digabung dengan berbagai bentuk pemikiran dan analisa dari macam-macam sumber yang kompeten. Knoweledge Management membantu organisasi dalam memperoleh wawasan dan pengertian dari pengalamannya. Kegiatan Knowledge Management yang spesifik dapat membantu organisasi dalam memperoleh, menyimpan dan mengembangkan knowledge untuk hal-hal seperti pemecahan masalah, pembelajaran dinamis, perencanaan strategis dan pengambilan keputusan. Pada PT Benua Cakra Petrolindo (BECAP), tingkat ketergantungan yang tinggi terhadap staf layanan teknis karena jabatan rangkap seorang service engineer dan sales engineer mengakibatkan beberapa masalah yakni keterlambatan respon perusahaan terhadap permintaan layanan pelanggan. Hal ini berpengaruh pada kemampuan perusahaan dalam menghadapi proses bisnis yang ada dan masalah yang timbul terutama pada kepuasan pelanggan. Kondisi ini tentu sangat tidak menguntungkan bagi sebuah perusahaan yang berperan sebagai perusahaan jasa yang khususnya memberikan pelayanan terbaik kepada pelanggan. Selain itu, tidak adanya suatu mekanisme yang mengatur pengetahuan yang ada di perusahaan membuat kinerja perusahaan menjadi tidak efektif dan tidak efisien

    Usage de la procalcitonine pour guider l’utilisation des antibiotiques en cas de sepsis

    No full text
    RĂ©sumĂ©Objectif : L’objectif est de discuter de l’intĂ©rĂȘt de la procalcitonine comme biomarqueur de l’infection bactĂ©rienne dans les situations de sepsis.Sources des donnĂ©es : Les donnĂ©es proviennent d’une recherche effectuĂ©e dans la base de donnĂ©es PubMed, sans limites de dates. Les Ă©tudes prospectives Ă  rĂ©partition alĂ©atoire contrĂŽlĂ©es et les rĂ©fĂ©rentiels internationaux publiĂ©s entre 2005 et 2015 ont Ă©tĂ© sĂ©lectionnĂ©s pour cet article Ă  l’aide des mots anglais antibiotic, procalcitonin, sepsis, septic shock.SĂ©lection des Ă©tudes et extraction des donnĂ©es : Les Ă©tudes comparatives prospectives Ă  rĂ©partition alĂ©atoire et les rĂ©fĂ©rentiels internationaux ont Ă©tĂ© sĂ©lectionnĂ©s pour cet article.Analyse des donnĂ©es : La procalcitonine est un marqueur spĂ©cifique et prĂ©coce de l’infection bactĂ©rienne. Sa supĂ©rioritĂ©, en matiĂšre de sensibilitĂ© et de spĂ©cificitĂ©, face Ă  d’autres marqueurs tels que la protĂ©ine C-rĂ©active a Ă©tĂ© dĂ©montrĂ©e. Certaines Ă©tudes ont montrĂ© que l’utilisation du dosage de la procalcitonine comme facteur dĂ©cisionnel dans la stratĂ©gie thĂ©rapeutique pour les patients septiques – en prĂ©sence ou non de choc – hospitalisĂ©s dans une unitĂ© de soins intensifs, a entraĂźnĂ© une diminution de la durĂ©e de l’antibiothĂ©rapie et de l’hospitalisation, sans rĂ©percussion dĂ©lĂ©tĂšre sur l’évolution clinique des patients. Une telle utilisation pourrait ĂȘtre associĂ©e Ă  des coĂ»ts de santĂ© moindres. Cependant, les protocoles et les seuils d’intervention utilisĂ©s dans les diffĂ©rentes Ă©tudes sont hĂ©tĂ©rogĂšnes et le taux de non-adhĂ©sion au protocole varie de 16 Ă  84 %, ce qui pourrait entraĂźner un biais de rĂ©sultats.Conclusion : La procalcitonine semble ĂȘtre un marqueur pronostic intĂ©ressant pour la prise en charge du sepsis. Cependant, d’autres Ă©tudes s’avĂšrent nĂ©cessaires pour valider cet outil. L’outil s’interprĂšte en concordance avec les autres rĂ©sultats de laboratoire et l’évaluation clinique du patient reste l’élĂ©ment prĂ©dominant dans la dĂ©cision thĂ©rapeutique.AbstractObjective: The objective is to discuss the value of procalcitonin as a biomarker of bacterial infection in cases of sepsis.Data sources and study selection: The PubMed database was searched without date restrictions. Randomized, prospective, controlled trials and international guidelines published between 2005 and 2015 were selected for this article using the following English words: antibiotic, procalcitonin, sepsis, septic shock.Data analysis: Procalcitonin is an early specific marker of bacterial infection. In terms of sensitivity and specificity, it has been shown to be superior to other markers, such as C-reactive protein. In septic patients—with or without shock—hospitalized in an intensive care unit, the use of procalcitonin as a decision-making factor in the treatment strategy has, in some studies, led to a decrease in the duration of antibiotic therapy and a shorter duration of hospital stay, with no negative impact on the patients’ clinical course. This tool may be associated with lower health-care costs. However, the protocols and intervention thresholds used in the different studies were heterogeneous, and the protocol noncompliance rates varied from 16 to 84%, which adds a potential bias to the results obtained.Conclusion: Procalcitonin seems to be a useful prognostic marker in sepsis management. Nevertheless, further studies are necessary to validate this usage. This tool should be interpreted in the context of other laboratory results, and the clinical evaluation of the patient remains the key component in therapeutic decision-making

    Utilisation de la procalcitonine pour le diagnostic et le suivi du traitement des infections respiratoires et du sepsis au Centre hospitalier de l’UniversitĂ© de MontrĂ©al

    No full text
    RĂ©sumĂ©Objectif : L’objectif est d’évaluer l’utilisation du dosage de la procalcitonine sur le plan des indications, de l’utilisation d’un algorithme dĂ©cisionnel, de la durĂ©e de l’antibiothĂ©rapie et du taux de mortalitĂ© pour les patients traitĂ©s au Centre hospitalier de l’UniversitĂ© de MontrĂ©al.MĂ©thode : L’étude, descriptive et rĂ©trospective, a analysĂ© 500 dossiers patients pour lesquels au moins un dosage de la procalcitonine a Ă©tĂ© effectuĂ© entre le 20 juillet 2014 et le 12 janvier 2015. Aucun critĂšre d’exclusion n’est retenu.RĂ©sultats : L’analyse comprend 722 dosages de procalcitonine. Les patients sont ĂągĂ©s de 67 ± 16 ans, 78,4 % prĂ©sentent une ou plusieurs comorbiditĂ©s et 79,4 % d’entre eux sont hospitalisĂ©s (32 % sont admis dans le service de chirurgie et 26,7 % dans le service de pneumologie). La grande majoritĂ© (77,8 %) des dosages de procalcitonine ont Ă©tĂ© effectuĂ©s pour mettre en Ă©vidence ou Ă©carter une infection respiratoire basse ou un sepsis. Dans 52,4 % des cas, l’algorithme dĂ©cisionnel propre Ă  l’établissement a Ă©tĂ© respectĂ©. L’utilisation du dosage de la procalcitonine semble ĂȘtre associĂ©e Ă  une diminution de la durĂ©e de l’antibiothĂ©rapie (estimĂ©e Ă  5,8 ± 1,4 jours en moyenne; environ 1 036 jours de traitement sauvĂ©s), sans rĂ©percussions sur le taux de mortalitĂ© des patients (9,3 % comparativement Ă  7,8 %, diffĂ©rence non significative).Conclusion : En cas d’infection respiratoire basse ou de sepsis, le dosage de la procalcitonine et l’utilisation d’un algorithme dĂ©cisionnel semblent ĂȘtre associĂ©s Ă  une rĂ©duction de l’utilisation des antibiotiques, sans rĂ©percussions sur le taux de mortalitĂ©. Une telle approche permettrait de limiter l’apparition de rĂ©sistances bactĂ©riennes et de rĂ©duire les coĂ»ts de santĂ©.AbstractObjective: The objective was to evaluate the use of procalcitonin assays in terms of indication, use of a decision algorithm, duration of antibiotic therapy, and mortality in patients treated at the Centre Hospitalier de l’UniversitĂ© de MontrĂ©al.Method: This is a descriptive, retrospective study based on the review of the charts of 500 patients for whom at least one procalcitonin assay was performed between July 20, 2014, and January 12, 2015. There were no exclusion criteria.Results: The analysis concerned 722 procalcitonin assays. The patients were 67 ± 16 years of age, and 78.4% had one or more comorbidities. In all, 79.4% of the patients were inpatients; 32% had been admitted for surgery and 26.7% for respiratory care. A total of 77.8% of the procalcitonin assays were performed to identify or rule out a lower respiratory tract infection or sepsis. In 52.4% of the cases, the decision algorithm, specific to this institution, was followed. The use of procalcitonin assays seemed to be associated with a decrease in the duration of antibiotic therapy, estimated at 5.8 ± 1.4 days on average, with 1,036 treatment days saved, with no impact on patient mortality rates (9.3% vs. 7.8%, difference nonsignificant).Conclusion: In cases of patients with lower respiratory tract infections or sepsis, procalcitonin assays and the use of a decision algorithm appear to be associated with a decline in antibiotic use, with no impact on mortality. This test can help limit the development of bacterial resistance and reduce healthcare costs
    • 

    corecore